Endometrial Cancer
Conditions
Brief summary
To verify the safety of omission of lymph node dissection in ultra-low-risk endometrial cancer (KGOG criteria), we examine the survival of women with ultra-low-risk endometrial cancer who do not undergo lymph node dissection
Interventions
PROCEDUREno lymph node dissection
do not undergo lymph node dissection
Sponsors
Seoul National University Hospital
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
19 Years to No maximum
Inclusion criteria
* endometrioid type * anticipated surgery omitting lymph node dissection for endometrial cancer * pelvis MRI, CA125 - satisfying KGOG criteria * no distant metastasis * age 19 or more
Exclusion criteria
* other cancer within 5 yr * previous hysterectomy * previous therapy for endometrial cancer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 3 year recurrence free survival | 3 year since surgery | 3 year recurrence free survival |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 5 year overall survival | 5 year since surgery | 5 year overall survival |
| surgery time | surgery visit | from surgery start to end |
| change of Functional Assessment of Cancer Therapy - General (FACT G) score from baseline | baseline - 1week - 5week - 3month - 6month | functional assessment of cancer therapy - general |
| change of Gynecologic Cancer Lymphedema Questionnaire - Korean (GCLQ-K) score from baseline | baseline - 5week - 6month - 12month - 18month - 24month - 36month - 48month - 60month | gynecologic cancer lymphedema questionnaire - Korean |
| 5 year recurrence free survival | 5 year since surgery | 5 year recurrence free survival |
| length of stay | surgery visit | from admission to discharge |
| transfusion | surgery visit | amount of transfusion |
| hemoglobin decline | surgery visit | change of hemoglobin level from baseline to postoperative lowest level |
| surgery complication | surgery visit | any surgery complications observed |
| change of Female Sexual Function Index (FSFI) score from baseline | baseline - 6month - 12month - 24month - 36month - 48month - 60month | female sexual function index |
Contacts
Primary Contactkidong kim, md
Outcome results
None listed